Tobrop

   
Product TOBROP Eye Drops
Composition Tobramycin 0.3%
Availability

5 ml vial packing

Therapeutic Group (Aminoglycoside) topical antibiotic.
Mode of Action Aminogycosides inhibit bacterial protein synthesis. These bind to the 30S bacterial ribosomal subunit and cause an alteration in codon : anticodon recognition (misreading of message) leading to death of bacteria.
Clinical Benefits
  • First line therapy for gram negative ocular infections.
  • The only antibiotic effective against Pseudomonas aeruginosa.
  • Broad spectrum antibiotic.
  • Excellent cure rates in Bacterial Conjunctivitis.
Adverse Effects

Nephro & oto-toxicity in systemic use,rarely in topical use.

Localized ocular toxicity & hypersensitivity including lid itching & swelling and conjunctival erythema. Occur in less than 3% of patients.

 

Yash Pharma Laboratories Pvt. Ltd. All Rights Reserved